Canaccord Genuity adjusted its outlook on Akero Therapeutics (NASDAQ: NASDAQ:AKRO) shares, raising the price target to $73 ...

Canaccord Genuity analyst Owen Humphries maintained a Buy rating on Kogan.com Ltd. (KGGNF – Research Report) on January 24 and set a price ...

Canaccord Genuity analyst Warren Jeffries maintained a Buy rating on BSA Limited (BSA – Research Report) on January 24 and set a price target ...

Canaccord Genuity updated its outlook on Stride Inc. (NYSE:LRN), increasing the price target to $130 from the previous $100, ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.82% of ...

Vertical Aerospace (NYSE:EVTL – Free Report) had its price target cut by Canaccord Genuity Group from $16.00 to $13.50 in a report issued on Friday,Benzinga reports. They currently have a buy rating ...

Analysts at Canaccord Genuity slightly raised their target price on exploration and development firm Greatland Gold from ...

Analysts at Canaccord Genuity initiated coverage on sales and marketing technology group Bango with a 'buy' rating and a ...

Canaccord Genuity, a midsize investment bank in Canada, leads the pack, having made $170 million. Goldman Sachs is a distant second: The bank pulled in close to $65 million. Here's the full list ...

Super Group's exit from U.S. betting and marketing efforts in Africa will produce even further gains for the stock price.

Canaccord Genuity raised its price target on Tesla (TSLA) to $404 per share from $298, citing optimism over the company’s growth, including in its energy business and possible robotics venture.

Canaccord Genuity Group Inc. (TSX: CF) is scheduled to release its third quarter fiscal 2025 financial results and supplementary financial information after Canadian markets close on Tuesday, February ...